Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: A trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

Agustin A. Garcia, Hal Hirte, Gini Fleming, Dongyun Yang, Denice D. Tsao-Wei, Lynda Roman, Susan Groshen, Steve Swenson, Frank Markland, David Gandara, Sidney Scudder, Robert Morgan, Helen Chen, Heinz Josef Lenz, Amit M. Oza

Research output: Contribution to journalArticlepeer-review

453 Scopus citations

Fingerprint Dive into the research topics of 'Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: A trial of the California, Chicago, and Princess Margaret Hospital phase II consortia'. Together they form a unique fingerprint.

Medicine & Life Sciences